Key Laboratory of Neuropsychiatric, Drug Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, China.
College of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, China.
Chem Biol Drug Des. 2021 Mar;97(3):592-606. doi: 10.1111/cbdd.13796. Epub 2020 Oct 5.
Andrographolide is a traditional Chinese medicine monomer with many pharmacological activities, but has potential nephrotoxicity. Here, we aim to investigate the relationship between modification of andrographolide structure and its nephrotoxicity. Twenty-three andrographolide derivatives were synthesized, and their structures were confirmed by H-NMR and HRMS. Nephrotoxicity of these compounds against human renal tubular epithelial (HK-2) cells was evaluated using the MTT assay. The results indicated that most of them had significantly reduced nephrotoxicity, especially compounds III, V, and IX , with IC values of 1,985, 1,300, and 806.9 μmol/L, respectively, which were obviously superior to andrographolide (IC 30.60 μmol/L). However, compounds I -I (IC values < 30 μmol/L), the 14-OH derivatives of andrographolide, showed higher nephrotoxicity than that of andrographolide. Three-dimensional quantitative structure-activity relationship (3D-QSAR) models of COMFA and COMSIA were established (COMFA: q = 0.639, r = 0.951; COMSIA: q = 0.569, r = 0.857). This model allowed proposing five new compounds with lower theoretical nephrotoxicity, which would be worthwhile to synthesize and evaluate. We believe that predicted models will help us to understand the structural modification requirements of andrographolide to reduce the nephrotoxicity, and further investigations will be needed to determine the mechanism involved in the effect of less nephrotoxic compounds.
穿心莲内酯是一种具有多种药理活性的中药单体,但具有潜在的肾毒性。在这里,我们旨在研究穿心莲内酯结构修饰与其肾毒性之间的关系。合成了 23 种穿心莲内酯衍生物,并通过 1 H-NMR 和 HRMS 确证了它们的结构。通过 MTT 法评估这些化合物对人肾小管上皮细胞(HK-2)的肾毒性。结果表明,它们中的大多数肾毒性明显降低,特别是化合物 III、V 和 IX,IC 值分别为 1,985、1,300 和 806.9 μmol/L,明显优于穿心莲内酯(IC 30.60 μmol/L)。然而,化合物 I -I(IC 值 < 30 μmol/L),即穿心莲内酯的 14-OH 衍生物,表现出比穿心莲内酯更高的肾毒性。建立了 COMFA 和 COMSIA 的三维定量构效关系(3D-QSAR)模型(COMFA:q = 0.639,r = 0.951;COMSIA:q = 0.569,r = 0.857)。该模型允许提出五个具有较低理论肾毒性的新化合物,值得合成和评估。我们相信,预测模型将有助于我们了解穿心莲内酯结构修饰以降低肾毒性的要求,进一步的研究将需要确定低肾毒性化合物作用涉及的机制。